As part of an initial pilot focused on oncology, the company is calling for proposals dedicated to gene fusions in solid tumors and molecular testing in blood cancers
New findings could have clinical implications for the IVF field, where debate still rages about the efficacy of implanting embryos with cells featuring too few or too many chromosomes
When used prior to other tests, the tool improved cost-effectiveness by 30 percent, an important consideration in areas with limited health care resources
A conversation with Megan Allyse, PhD, assistant professor of biomedical ethics at Mayo Clinic
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.